Repurposing Existing Drugs for the Treatment of COVID-19

The rapid global spread and significant mortality associated with the coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral infection has spurred an urgent race to find effective treatments. Repurposing existing drugs is a particularly attractive...

Descripción completa

Detalles Bibliográficos
Autores principales: Farne, Hugo, Kumar, Kartik, Ritchie, Andrew I., Finney, Lydia J., Johnston, Sebastian L., Singanayagam, Aran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2020
Materias:
Focused Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640626/
https://www.ncbi.nlm.nih.gov/pubmed/32692580
http://dx.doi.org/10.1513/AnnalsATS.202005-566FR

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640626/
https://www.ncbi.nlm.nih.gov/pubmed/32692580
http://dx.doi.org/10.1513/AnnalsATS.202005-566FR

Ejemplares similares